Rosalind Franklin University Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2005
NCT00641433
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Mount Sinai Hospital, Chicago | Rosalind Franklin University of Medicine and Science

Active Ingredients

Drugs in Phase 4 Trials (2)

haloperidol (haldol) (1 trial)

lorazepam (ativan) (1 trial)

Drugs in Other Trials (2)

collagen-silver (1 trial)

silver sulfadiazine (silvadene) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Psychomotor Agitation (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4